Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00390104 · ClinicalTrials.gov registry record
Molecular Analysis of Patients With Neuromuscular Disease
A clinical trial of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00390104 is a study of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 1,000 participants, above the 73-participant average among 6 other Limb Girdle Muscular Dystrophy trials with a reported enrollment target (1270% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00390104, a study of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00390104
The ClinicalTrials.gov registry entry for NCT00390104 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 6 other Limb Girdle Muscular Dystrophy trials with a reported enrollment target (1270% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Limb Girdle Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT00390104 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00390104 about?
NCT00390104 is a clinical study titled "Molecular Analysis of Patients With Neuromuscular Disease". The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy ...
What is the current status of trial NCT00390104?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2002-01. Estimated completion is 2027-12-31.
What conditions does trial NCT00390104 study?
This clinical trial studies the following conditions: Limb Girdle Muscular Dystrophy, Neuromuscular; Disorder, Hereditary, Duchenne/Becker Muscular Dystrophy.
Who is sponsoring clinical trial NCT00390104?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00390104 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Limb Girdle Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
RECRUITING · Phase 1
-
LGMD R1 Natural History Study
RECRUITING
-
A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)
ACTIVE NOT RECRUITING · Phase 1
-
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4
ACTIVE NOT RECRUITING · Phase 3
-
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
ACTIVE NOT RECRUITING
-
Biomarker Development in LGMD2i
COMPLETED
Explore more on PlainTrial
Limb Girdle Muscular Dystrophy
All registered trials for this condition
Neuromuscular; Disorder, Hereditary
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.